Published in Semin Immunopathol on April 30, 2009
Gap junctions. Compr Physiol (2012) 1.59
Connexins and diabetes. Cardiol Res Pract (2012) 0.81
Connexins and their channels in inflammation. Crit Rev Biochem Mol Biol (2016) 0.77
Ginkgolide B Inhibits JAM-A, Cx43, and VE-Cadherin Expression and Reduces Monocyte Transmigration in Oxidized LDL-Stimulated Human Umbilical Vein Endothelial Cells. Oxid Med Cell Longev (2015) 0.75
Inflammation in atherosclerosis. Nature (2002) 28.92
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 12.21
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (1992) 11.83
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest (1993) 9.56
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79
The gap junction communication channel. Cell (1996) 5.95
Cardiac malformation in neonatal mice lacking connexin43. Science (1995) 5.51
Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev (2006) 5.27
Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev (2003) 4.87
Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol (1995) 4.08
Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med (2002) 3.96
Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol (2003) 3.75
Gap junctions and the connexin protein family. Cardiovasc Res (2004) 3.66
Cell biology of atherosclerosis. Annu Rev Physiol (1995) 3.60
Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med (2008) 3.49
Life cycle of connexins in health and disease. Biochem J (2006) 3.44
Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol (2007) 3.36
Regulation of blood flow in the microcirculation. Microcirculation (2005) 2.68
Gap junctions: structure and function (Review). Mol Membr Biol (2002) 2.58
Gap junctions and connexin-interacting proteins. Cardiovasc Res (2004) 2.56
Female infertility in mice lacking connexin 37. Nature (1997) 2.20
Unique and shared functions of different connexins in mice. Curr Biol (2000) 2.10
Connexin40 regulates renin production and blood pressure. Kidney Int (2007) 1.91
Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res (1998) 1.90
Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol (1998) 1.89
Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol (1998) 1.85
Connexin45 cannot replace the function of connexin40 in conducting endothelium-dependent dilations along arterioles. Circ Res (2007) 1.83
Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest (1997) 1.83
An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes (2003) 1.77
Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res (2000) 1.71
Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med (2006) 1.70
Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br J Pharmacol (2004) 1.61
Defective vascular development in connexin 45-deficient mice. Development (2000) 1.57
Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. Am J Physiol (1995) 1.54
Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis (2006) 1.51
The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J Cell Biol (1997) 1.51
Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol (2003) 1.48
Gap junctions in the control of vascular function. Antioxid Redox Signal (2009) 1.47
The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol (2000) 1.46
Connexin channels, connexin mimetic peptides and ATP release. Cell Commun Adhes (2003) 1.45
Heterocellular contact at the myoendothelial junction influences gap junction organization. Circ Res (2005) 1.44
Differential regulation of distinct types of gap junction channels by similar phosphorylating conditions. Mol Biol Cell (1995) 1.42
Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res (2007) 1.42
Unique conductance, gating, and selective permeability properties of gap junction channels formed by connexin40. Circ Res (1995) 1.36
Endothelium-specific replacement of the connexin43 coding region by a lacZ reporter gene. Genesis (2001) 1.36
Contribution of connexins to the function of the vascular wall. Cardiovasc Res (2004) 1.35
Coronary artery stents: Part I. Evolution of percutaneous coronary intervention. Anesth Analg (2008) 1.32
Connexin-caused genetic diseases and corresponding mouse models. Antioxid Redox Signal (2009) 1.27
Mechanism of heptanol-induced uncoupling of cardiac gap junctions: a perforated patch-clamp study. Am J Physiol (1992) 1.27
A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med (1999) 1.24
Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy. Circulation (2003) 1.24
Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation (2003) 1.22
Connexins in vascular physiology and pathology. Antioxid Redox Signal (2009) 1.22
Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med (2005) 1.22
Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2002) 1.21
Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice. Am J Physiol Cell Physiol (2008) 1.19
Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta (2004) 1.19
Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics (2003) 1.16
Mimetic peptides as blockers of connexin channel-facilitated intercellular communication. Cell Commun Adhes (2008) 1.16
What's where and why at a vascular myoendothelial microdomain signalling complex. Clin Exp Pharmacol Physiol (2008) 1.16
Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40. J Cell Sci (2003) 1.15
Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment. Arterioscler Thromb Vasc Biol (2003) 1.15
RXP-E: a connexin43-binding peptide that prevents action potential propagation block. Circ Res (2008) 1.15
Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol (2002) 1.14
Connexin-GFPs shed light on regulation of cell-cell communication by gap junctions. Curr Drug Targets (2002) 1.13
Identification of a novel peptide that interferes with the chemical regulation of connexin43. Circ Res (2006) 1.12
Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation (2006) 1.11
Inhibition of gap junction communication in alveolar epithelial cells by 18alpha-glycyrrhetinic acid. Am J Physiol (1999) 1.10
Gap junctions assemble in the presence of cytoskeletal inhibitors, but enhanced assembly requires microtubules. Exp Cell Res (2002) 1.09
Regulation of vascular connexin43 gene expression by mechanical loads. Circ Res (1998) 1.09
Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.09
Formation of the gap junction nexus: binding partners for connexins. J Physiol Paris (2002) 1.08
Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int (2006) 1.05
Incorporation of connexins into plasma membranes and gap junctions. Cardiovasc Res (2004) 1.04
Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol (2002) 1.03
Dissection of two Cx37-independent conducted vasodilator mechanisms by deletion of Cx40: electrotonic versus regenerative conduction. Am J Physiol Heart Circ Physiol (2008) 1.01
Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine (1998) 1.00
Gap-junctional coupling between neutrophils and endothelial cells: a novel modulator of transendothelial migration. J Leukoc Biol (2003) 0.99
Connexin43 modulates neutrophil recruitment to the lung. J Cell Mol Med (2009) 0.96
Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol (1997) 0.95
Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans. Fundam Clin Pharmacol (2008) 0.95
Role of cytoskeletal elements in the recruitment of Cx43-GFP and Cx26-YFP into gap junctions. Cell Commun Adhes (2001) 0.94
Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol (2001) 0.93
Limiting burn extension by transient inhibition of Connexin43 expression at the site of injury. Br J Plast Surg (2005) 0.93
Gap junctional hemichannels in the heart. Acta Physiol Scand (2003) 0.92
Gap junctional communication between vascular cells. Induction of connexin43 messenger RNA in macrophage foam cells of atherosclerotic lesions. Am J Pathol (1993) 0.92
Connexins pave the way for vascular communication. News Physiol Sci (2004) 0.91
Endothelial mediators and communication through vascular gap junctions. Biol Chem (2006) 0.90
Nonredundant gap junction functions. News Physiol Sci (2003) 0.90
Increasing gap junctional coupling: a tool for dissecting the role of gap junctions. J Membr Biol (2007) 0.90
Shear stress and cyclic circumferential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell Commun Adhes (2006) 0.89
Interaction of connexins with protein partners in the control of channel turnover and gating. Biol Cell (2002) 0.89
Signaling across myoendothelial gap junctions--fact or fiction? Cell Commun Adhes (2008) 0.88
Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res (2008) 0.88
Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40. J Vasc Res (2002) 0.88
Functional differences between human Cx37 polymorphic hemichannels. J Mol Cell Cardiol (2009) 0.87
Connexin37 in normal and pathological development of mouse heart and great arteries. Dev Dyn (2000) 0.87
Intercellular communication in atherosclerosis. Physiology (Bethesda) (2009) 0.87
Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell (2012) 2.45
Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost (2009) 2.05
Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation (2004) 1.90
Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med (2006) 1.70
Mutations in connexin genes and disease. Eur J Clin Invest (2010) 1.56
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest (2005) 1.55
Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis (2006) 1.51
Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res (2005) 1.49
The natural cardioprotective particle HDL modulates connexin43 gap junction channels. Cardiovasc Res (2011) 1.43
Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation (2005) 1.40
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood (2012) 1.35
Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction. J Clin Invest (2012) 1.24
Connexins in vascular physiology and pathology. Antioxid Redox Signal (2009) 1.22
Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta (2004) 1.19
Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest (2008) 1.16
Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation (2006) 1.11
Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis. J Am Heart Assoc (2012) 1.10
CFTR in a lipid raft-TNFR1 complex modulates gap junctional intercellular communication and IL-8 secretion. Biochim Biophys Acta (2008) 1.10
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc Res (2003) 1.07
Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb Haemost (2011) 1.06
Gap junction protein Cx37 interacts with endothelial nitric oxide synthase in endothelial cells. Arterioscler Thromb Vasc Biol (2010) 1.02
Connexin 37 limits thrombus propensity by downregulating platelet reactivity. Circulation (2011) 0.98
Connexin channel-dependent signaling pathways in inflammation. J Vasc Res (2010) 0.98
Stabilization of atherosclerotic plaques: an update. Eur Heart J (2013) 0.96
Connexin43 modulates neutrophil recruitment to the lung. J Cell Mol Med (2009) 0.96
Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation. Carcinogenesis (2010) 0.93
Lymphatic vessels: an emerging actor in atherosclerotic plaque development. Eur J Clin Invest (2015) 0.93
Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells. J Mol Cell Cardiol (2012) 0.92
FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature. J Clin Invest (2015) 0.89
Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res (2008) 0.88
Adipokines at the crossroad between obesity and cardiovascular disease. Thromb Haemost (2014) 0.88
Functional differences between human Cx37 polymorphic hemichannels. J Mol Cell Cardiol (2009) 0.87
Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation (2006) 0.87
Intercellular communication in atherosclerosis. Physiology (Bethesda) (2009) 0.87
Connexins in atherosclerosis. Biochim Biophys Acta (2012) 0.87
Role of the growth arrest-specific gene 6 (gas6) product in thrombus stabilization. Blood Cells Mol Dis (2006) 0.84
Regulation of cardiovascular connexins by mechanical forces and junctions. Cardiovasc Res (2013) 0.84
Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice. Cell Commun Adhes (2003) 0.83
Connexins in atherosclerosis. Adv Cardiol (2006) 0.82
Roles of connexins in atherosclerosis and ischemia-reperfusion injury. Curr Pharm Biotechnol (2012) 0.82
Connexin37: a potential modifier gene of inflammatory disease. J Mol Med (Berl) (2007) 0.81
Atherosclerosis at arterial bifurcations: evidence for the role of haemodynamics and geometry. Thromb Haemost (2016) 0.79
Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice. Cardiovasc Res (2014) 0.79
Role of connexins and pannexins in cardiovascular physiology. Cell Mol Life Sci (2015) 0.78
Connexins in leukocytes: shuttling messages? Cardiovasc Res (2004) 0.78
Mutations in cardiovascular connexin genes. Biol Cell (2014) 0.78
Connexins: new genes in atherosclerosis. Ann Med (2007) 0.77
Vascular connexins in restenosis after balloon injury. Methods Mol Biol (2013) 0.77
Lack of association between connexin40 polymorphisms and coronary artery disease. Atherosclerosis (2012) 0.77
Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques. Thromb Haemost (2007) 0.76
In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106. Mol Imaging (2014) 0.76
Molecular role of Cx37 in advanced atherosclerosis: a micro-array study. Atherosclerosis (2009) 0.76
A starting point for structure function relationships in the canine pulmonary veins. Cardiovasc Res (2002) 0.75
Risky communication in atherosclerosis and thrombus formation. Swiss Med Wkly (2012) 0.75
Biomechanical factors in cardiovascular disease. Cardiovasc Res (2013) 0.75